2nd Quarter - Report

ABIOMED, INC for ABIOMED, INC

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 108, H.R. 184, Medical Device Access and Innovation Protection Act. Legislation related to the medical device excise tax. Issues relating to the Medical Device User Fee Agreement with respect to promoting innovation in the medical technology industry. Issues related to Ensuring Access to Critical Breakthrough Products Act. Issues related to implementation of PL 112-144, the Food and Drug Administration Safety and Innovation Act. Issues related to implementation of the 21st Century Cures Act. Issues related to postmarket regulation of medical devices. Issues related to awareness of cardiovascular disease and the new field of heart recovery.

LobbyistCovered position, as disclosed
MELISSA DODSON SCHOOLEY —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 184 (115th), S. 108 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.